#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic neuroendocrine tumour IPEX syndrome Extraskeletal ossification Deafness neurosensory Rhabdomyosarcoma Cystic fibrosis respiratory infection suppression Encephalopathy neonatal Follicle centre lymphoma follicular grade I, II – III Mantle cell lymphoma stage IV Congenital nephrogenic diabetes insipidus Mantle cell lymphoma recurrent Adult T-cell lymphoma/leukaemia refractory Lung adenocarcinoma Cryoglobulinaemia Fragile X syndrome More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Treatment Glycogen storage disease type I – Treatment Synovial sarcoma Breast angiosarcoma metastatic – Diagnostics Alternating hemiplegia of childhood – Treatment Retinitis pigmentosa – Life with Disease Glomerulonephritis membranous – Basic Information Mast cell activation syndrome – Basic Information Lymphangiosarcoma – Basic Information Netherton’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desvenlafaxine Benzoate Plasma Amcenestrant ABY-271 Fenebrutinib Alanyl Glutamine VTX2735 SODIUM Basiliximab Cefaclor ATOVAQUONE Ioversol Mva-Hbvac Valemetostat Tosilate Dog Epithelia Xaluritamig AZD5148 HYPOCHLOROUS ACID Fosfomycin Trometamol AZD4512 1,3-BUTYLENE GLYCOL More therapies…

    Learn about Your Condition

    Cutaneous sarcoidosis Plasmablastic lymphoma Malignant melanoma of eyelid Chronic hepatic failure Myeloproliferative neoplasm Chondroplasty Diphtheria Critical illness Short stature Cardiac valve disease Pyelonephritis Infertility Labour induction Macular telangiectasia Craniosynostosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Safety and Effectiveness of Adalimumab as Initial Treatment for Newly Diagnosed Crohn’s Disease Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Adalimumab
    The Netherlands

  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6

  • Study on the Effect of Intensive Chemotherapy with FOLFOXIRI Compared to Standard Treatment for Patients with Localized Colon Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Spain

  • Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Norucholic Acid
    Austria Belgium Denmark France Germany Hungary +4

  • Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    Belgium France

  • Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • ORG-129
    Austria Denmark Germany Italy Poland Spain
Previous Page
1 … 63 64 65 66 67 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!